In A Recent Case (Cardionet, LLC v. Infobionic, Inc.) Demonstrating The Patentability Of Medical Devices In The U.S., The Federal Circuit Found A Cardiac Monitor Device Not Abstract (and, Therefore, Patent Eligible) Under The Supreme Court's Alice Test
Marshall, Gerstein & Borun is a full service intellectual property law firm that protects, enforces and transfers the intellectual property of clients in more than 150 countries worldwide. Nearly half the Firm’s professionals have been in-house as general counsel, patent counsel, technology transfer managers, scientists or engineers, and offer seasoned experience in devising and executing IP strategy and comprehensive IP solutions. Learn more at www.marshallip.com.
In a recent case (Cardionet, LLC v. Infobionic, Inc.) demonstrating the patentability of medical devices in the U.S., the Federal Circuit found a cardiac monitor device not abstract...
In a recent case (Cardionet, LLC v. Infobionic, Inc.)
demonstrating the patentability of medical devices in the U.S., the
Federal Circuit found a cardiac monitor device not abstract (and,
therefore, patent eligible) under the Supreme Court's
Alice test.
A common test to demonstrate patent eligibility is to show an
"improvement" in the underlying technology.
The Federal Circuit found that test was sufficiently met for the
cardiac device: "In our view, the claims focus on a specific
means or method that improves cardiac monitoring technology; they
are not directed to a result or effect that itself is the abstract
idea and merely invoke generic processes and machinery."
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
